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A b s t r a c t  
A simple and accurate method was developed for the validation of the Econazole using Fluconazole 
as internal standard with short time of 10 minutes .Optimization of chromatography technique was 
used during the preparation of this analysis.  The method carried out using reversed phase of HPLC. 
Chromatography using Phenomenex Luna C18 Column (250mm x 4.6mm i.d, 5øm) as the 
stationary phase and mobile phase of solvent A and B of 0.5% Triethylamine at pH 6.5 and 
Acetonitrile at pH 3.5. Wavelength was fixed at 260nm and flow rate at 0.6mL/min. Validation 
studies was achieved by using the fundamental parameters, including accuracy, precision, 
selectivity, sensitivity, linearity and range, stability studies, limit of detection (LOD) and limit of 
quantitation (LOQ). Retention time obtained for Econazole and Fluconazole are 7.7 minutes and 
5.18 minutes. It shows recovery at 93.5% which is more precise and accurate compared to the other 
Econazole method. Hence, a simple and accurate method of validation of Econazole in drug free 
plasma was developed and validated. 
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Introduction 
Econazole is an antifungals used to treat infections caused by 
fungi. It is an imidazole derivative and its chemical name is 1-{2-
[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-
imidazole.[1,2] Its chemical structure is shown in Figure 1. They 
work by killing the fungus or preventing its growth. It is 
therapeutically used for athleteÊs foot, jock itch, ringworm, and 
other fungal skin infections (candidiasis). It is also used to treat a 
skin condition known as pityriasis (tinea versicolor), a fungal 
infection that causes a lightening or darkening of the skin of the 
neck, chest, arms, or legs. [3] [4] [5] 
 
 
Figure 1: Chemical structure of Econazole. 
Econazole interacts with 14-đ demethylase, a cytochrome P-450 
enzyme necessary to convert lanosterol to ergosterol. Econazole 
inhibits the synthesis of ergosterol which is an essential component 
of the fungal cell membrane; this will increase the cellular 
permeability causing leakage of cellular contents. Systemic 
absorption of Econazole nitrate is low after topical application. Drug 
concentrations were found in the stratum corneum. Inhibitory 
concentrations were achieved in the epidermis and as deep as the 
middle region of the dermis [5].  
There are already several bioanalytical methods developed for 
Econazole. Determination of Econazole with HPLC was performed 
by A.Mark Dyasand Hugh Delargy and acquired a recovery of 
98.5% [6]. This paper describes a new sensitive bioanalytical 
method for Econazole using RP-HPLC method. By this method, 
chromatographic conditions have been optimized and validated in 
accordance to FDA guidelines. This result in a more sensitive, less 
time consumption and easier method of quantification compared to 
the other existing methods and it gives better recovery from the 
human plasma, which is 93.5%. 
Experimental 
Chemicals and reagents 
Acetonitrile and Triethylamine (both HPLC grade) were obtained 
from Merck, Darmstadt, and West Germany. Ammonium acetate 
(molecular biology reagent grade) was obtained from Systerm, 
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Malaysia. Potassium dihydrogen phosphate was obtained from 
HmBG. Methanol obtained from QREC. And HPLC grade water 
was used throughout. 
Instrumentation and Chromatographic Condition 
HPLC chromatographic separation was performed on a Shimadzu 
liquid chromatographic system equipped with a LC-20AD solvent 
delivery system (pump), SPD-20A photo diode array detector, and 
SIL-20ACHT injector with 50μL loop volume. LC solution version 
1.25 was applied for data collecting and processing (Shimadzu, 
Japan). The HPLC was carried out at a flow rate of 0.6mL/min 
using a mobile phase of 0.5% Triethylamine (pH 6.5) and 
Acetonitrile (85:15% v/v). The mobile phase was prepared daily, 
filtered through a 0.45μm membrane filter (Millipore) and sonicated 
before use. A Thermo C18 column (250mm ï 4.6mm i.d., 5μ) was 
used for the separation.  
Preparation of Stocks Solution 
100mg of Econazole was weighed accurately and dissolved in 
100mL of methanol into the 100mL light resistance volumetric 
flask. The final solution was containing 1mg/mL. It was labeled and 
the solution was stored in a refrigerator below 8oC. 
Sample Preparation (Protein Precipitation)  
The blank plasma sample was prepared by adding 0.5mL of 
plasma and 0.5mL of TCA in Eppendorf tube and vortex for 2 min. 
Then centrifuge the solution at 4000 RPM for 7min. The 
supernatant liquid is taken and transferred to another Eppendorf 
tube. Centrifuge the solution at 4000 RPM for 2 minutes and 
transferred to HPLC vials. In protein precipitation, Trichloroacetic 
acid (TCA) is used to remove the protein by denaturation and 
precipitation [7] (Figure. 2) 
 
 
Figure. 2. Typical chromatogram of spiked plasma 
 
Validation 
The method was validated in terms of Specificity, Accuracy, 
Precision, Linearity and Range, Stability, and Recovery. 
Specificity 
The specificity was established by preparing an Econazole 
standard and injected 5 times into RP-HPLC system as per the 
procedure. The specificity method described was investigated by 
drug free human plasma. Under the proposed assay condition, 
internal standard and Econazole had a retention time 3.8 minutes 
and 6 minutes respectively. Rests of the peaks were due to the 
plasma components. Econazole and internal standard were very 
well resolved under the proposed chromatographic conditions. 
None of the drug free human plasma samples studied in this assay 
in endogenous interference at this retention time.  
Accuracy  
The accuracy describes the closeness of mean test results 
obtained by the method to the true value (concentration) of the 
analyte. Accuracy is determined by using seven different 
concentration of Econazole (5, 10, 20, 30, 40, 50 and 70 ng/mL). It 
should within the range of 80-120%. [8] 
 
%ܰ݋݈݉݅݊ܽ ൌ
ܯ݁ܽݏݑݎ݁݀ ܿ݋݊ܿ݁݊ݐݎܽݐ݅݋݊ 
ܣܿݐݑ݈ܽ ܿ݋݊ܿ݁݊ݐݎܽݐ݅݋݊
 ൈ 100% 
Precision 
The precision of an analytical method describes the closeness of 
individual measures of an analyte when the procedure is applied 
repeatedly to multiple aliquots of a single homogeneous volume of 
biological matrix.  
 
ܲݎ݁ܿ݅ݏ݅݋݊ ൌ ௌ௧௔௡ௗ௔௥ௗ ஽௘௩௜௔௧௜௢௡ 
ெ௘௔௡
ܺ100% 
Linearity and Range 
The linearity of the method was determined at seven different 
concentration of Econazole (5, 10, 20, 30, 40, 50 and 70 ng/mL).  
The calibration curve was constructed by plotting absorbance 
against different concentration of Econazole (5, 10, 20, 30, 40, 50 
and 70 ng/mL). [12] 
Linearity, Rñ is found to be 5-70ng/mL. The regression equation 
was found to be y = 1.0005 X - 0.4032 with coefficient of 
correlation R2 = 0.9994 (Figure. 3 and Table 1).  
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Figure. 3.  Calibration curve of Econazole 
Table 1. Linearity studies 
Concentration Absorbance 
0 0 
5 4.9540 
10 9.6352 
20 18.6487 
30 29.9954 
40 38.6954 
50 49.9564 
70 69.9924 
Stability 
Stability test need to be performed in validation analysis of drugs to 
ensure the products is stable even after a certain time frame to 
avoid any other interaction, and the reproducibility of the curve 
should be monitor over the time. In stability studies of analysis of 
Econazole, an optimum chromatography condition is maintained as 
such that with the mobile phase of tri-ethylamine and with organic 
phase of Acetonitrile with ratio of 85:15, and flow rate of 
0.6mL/min. The concentration of each sample is 5ng, 10ng, 20ng, 
30ng, 40ng, 50ng and 70ng respectively.  
5 repeated injections were given to the plasma sample: 
 
݉݁ܽ݊ ݎ݁ݏ݌݋݊ݏ݁ ݋݂ ݏݐܾ݈ܽ݅ݐݕ ݏܽ݉݌݈݁
݉݁ܽ݊ ݎ݁ݏ݌݋݊ݏ݁ ݋݂ ܿ݋݉݌ܽݎ݅ݏ݋݊ ݏܽ݉݌݈݁ 
  ൈ 100  
 
The results of stability studies are in Table 2. 
The accepted limit range of the stability studies should be within 
80% - 120%. 
Short Term Stability Studies 
In short term room temperature stability of drug, the % Nominal 
was 96.84% for LQC and 98.77% for HQC level. The results of 
short term storage at room temperature stability indicated no 
degradation of Econazole. Results are shown in Table 3. 
 
Table 2. Stability studies 
Nominal Concentration (ng/mL)
LQC HQC
5.0 70.0
4.523 68.852
4.896 69.635
4.471 69.047
4.632 68.531
4.558 67.995
Mean 4.616 68.812
S.D 0.167103261 0.608400362
C.V (%) 3.620087987 0.884148639
% Nominal 92.32 98.30285714
N 5 5
 
Table 3. Short Term Room Temperature Stability of Drug
Nominal Concentration (ng/mL)
LQC HQC
5 70
4.8941 69.3526
4.6395 68.7497
4.9521 69.5214
4.8837 68.9587
Mean 4.84235 69.1456
S.D 0.138541293 0.353903499
C.V (%) 2.861034281 0.5118236
% Nominal 96.847 98.77942857
N 5 5
Auto Sampler Stability Studies 
auto sampler stability of drug in plasma, the % Nominal was 
99.16% for LQC and 99.26% for HQC. Results are shown in Table 
4. 
Table 4. Auto sampler Stability of Drug in Plasma 
Concentration (ng/mL) 
LQC HQC 
5 70
5.0185 69.8547
4.8897 69.9921
4.9967 69.0319
4.8859 68.5974
5.0014 69.9581
Mean 4.95844 69.48684
S.D 0.065007369 0.634580285
C.V (%) 1.31104478 0.913238082
% Nominal 99.1688 99.26691429
N 5 5
Freeze Thaw Stability Studies 
y = 1.000x ‐ 0.403
R² = 0.999
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The blood plasma is taken out from the fridge and allowed to 
defrost in room temperature for 30minutes. 5øl of plasma is taken 
into Eppendorf tube and 5øl TCA is added for protein precipitation. 
The result is shown in Table 5. 
      Table 5. Freeze/Thaw Cycle Stability of Drug 
  Concentration (ng/mL) 
LQC HQC 
5 70 
4.8964 68.7124
4.9902 69.1598
4.8632 69.9231
4.9921 68.9945
4.8762 69.0175
Mean 4.92362 69.16146
S.D (μ) 0.062774533 0.455618605
C.V (%) 1.274967058 0.658775284
% Nominal 98.4724 98.80208571
N 5 5 
Long Term Stability Studies 
For long term stability studies, both standard and sample solutions 
were analyzed over the period of 72 hours. Results are shown in 
Table 6. 
 
        Table 6. Long Term Stability of Drug 
  Concentration (ng/mL) 
LQC HQC
5 70
4.6592 69.0213
4.8915 68.9972
5.9978 69.1524
4.8979 68.0175
4.9912 69.8513
Mean 5.08752 69.00794
S.D (μ) 0.523384378 0.654482622
C.V (%) 10.28761318 0.948416403
% Nominal 101.7504 98.58277143
N 5 5
 
 
Recovery 
Recovery is a ratio of the detector response of an analyte from an 
extracted sample to the detector response of the analyte from an 
unextracted sample containing the same amount of analyte that 
was added to the extracted sample. 
Recovery experiments should be performed by comparing the 
analytical results for extracted samples at three concentrations 
(low, medium, and high) with unextracted standards that represent 
100% recovery.  
 
%ܴ݁ܿ݋ݒ݁ݎݕ ൌ
ܷ݊݁ݔݐݎܽܿݐ݁݀ ݏܽ݉݌݈݁
ܧݔݐݎܽܿݐ݁݀ ݏܽ݉݌݈݁
 ൈ 100% 
 
The percentage recovery of Econazole was found to be in the 
range of 97.36% to 99.93% and the results are presented in the 
Table 7. 
             Table 7. Recovery studies 
Extracted Unextracted % Recovery
11524 13526 85.19888
10458 14025 74.56684
11369 13894 81.82669
10895 14008 77.77698
11395 13975 81.53846
LOD and LOQ (limit of detection and limit of 
quantification) 
LOD and LOQ were calculated as 3.3 Ĕ /S and 10 Ĕ /S respectively; 
where Ĕ is the standard deviation of the response (y-intercept) and 
S is the slope of the calibration plot. The LOD and LOQ for 
Econazole were predicted basing on the parameters of standard 
error of estimate and slope, calculated from linearity of the 
response data of Econazole are 3.0 ng/mL and 8.0 ng/mL 
respectively.  
Conclusion 
An HPLC based method of Econazole has been developed and 
validated in drug free human plasma. The sensitivity and simplicity 
of the method makes it suitable for pharmacokinetic studies and 
can be interchangeable in clinical practice.  
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